DGE invites life science professionals to attend the 3rd Diversity In Clinical Trials Conference being held on May 15-16, 2024 at the Inn at Penn Philadelphia. The conference offers an valuable forum for meaningful interactions to understand the intricacies of and benefits of pursuing diverse enrollment in clinical studies.
The event is hosted by Dynamic Global Events (“DGE”), a global leader in organizing B2B events. The global event company caters to the dynamic informational and networking needs of the pharma, biotech, medical devices, and all healthcare industries.
New insights and successful strategies are pivotal for better clinical trial results. Pharma colleagues gather for a focused approach towards diversity, equity, and inclusion (DEI) for clinical trials. Having a complete understanding of the complexities and challenges of diverse participation in clinical trials will help organizations make the necessary changes in their planning and execution.
The event will be attended by a diverse group of industry veterans who will share their experience and views on improving diversity in organizations. The well-rounded agenda of the conference explores all issues and challenges of diverse enrolment in clinical trials.
The conference agenda includes:
- Examining the past and present issues of DCT, the measures taken to solve these issues, and ways of improvisation for future achievements
- Understanding the pivotal role of DCT in the life sciences industry for developing the most effective treatments for patients
- A great learning session offering tips to avoid repeating mistakes and discussing new avenues for improvement and development
- An important discussion on Digital Accessibility for Clinical Trial Diversity
After the registration, the event starts with the chairperson’s opening remarks. This is followed by speaker sessions, interaction, group discussions and networking among the attendees of the conference.
To learn more please visit https://ibn.fm/EBGQd.
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]
InvestorWire is powered by IBN